A safety and efficacy of the cutting an ampulla of vater in ERCP

A safety and efficacy of the cutting an ampulla of vater in ERCP - H-cut study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030511

Enrollment

Registered

2017-12-21

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary deseases

Interventions

Cutting an ampulla of vater

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. over 20 years of age 2. Patients who need biliary cannulation in ERCP for biliary disease

Exclusion criteria

Exclusion criteria: 1. Not naiive papilla 2. Patients who need ERP for pancreatic desease 3. Patients considered ineligible for this study

Design outcomes

Primary

Measure	Time frame
Adverese events rate Early:Post ERCP pancreatitis, bleeding,perforation, et al. Late:Stenosis of the papilla, pancreatitis, cholangitis, cholecystitis	—

Secondary

Measure	Time frame
Efficacy Success rate of bilialy cannulation Total procedure time	—

Countries

Japan

Contacts

Public ContactNozomi Okuno

Aichi Cancer Center Gastroenterology

nokuno@aichi-cc.jp052-762-611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026